Stay updated on Pembrolizumab for Advanced Acral Lentiginous Melanoma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab for Advanced Acral Lentiginous Melanoma Clinical Trial page.

Latest updates to the Pembrolizumab for Advanced Acral Lentiginous Melanoma Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe revision label on the page was updated from v3.6.5 to v3.6.6, indicating a deployment/update to the site.SummaryDifference0.1%

- Check20 days agoNo Change Detected
- Check27 days agoNo Change Detected
- Check34 days agoChange DetectedA new revision entry v3.6.5 appears, replacing the previous v3.6.4. This indicates an update to the site's revision/version, likely a template or system change rather than content changes.SummaryDifference0.1%

- Check49 days agoChange DetectedRevision label updated from v3.6.3 to v3.6.4 on the page. This indicates a new version of the page template or metadata, with no substantive study details altered.SummaryDifference0.1%

- Check70 days agoChange DetectedRevision number updated from v3.6.2 to v3.6.3, indicating a small page update; the visible study information appears unchanged.SummaryDifference0.1%

- Check77 days agoChange DetectedThe page revision was updated from v3.6.0 to v3.6.2, indicating an updated version of the study details page. This likely reflects backend or formatting updates rather than changes to the trial information.SummaryDifference0.1%

- Check92 days agoChange DetectedThe page now indicates that recruitment has ended and adds new help/navigation sections (How to Read a Study Record, Common Questions, How to Join a Study). It also shows a revision stamp (Revision: v3.6.0) and updates the Intervention/Treatment label formatting.SummaryDifference0.5%

Stay in the know with updates to Pembrolizumab for Advanced Acral Lentiginous Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for Advanced Acral Lentiginous Melanoma Clinical Trial page.